secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2024-04-25T23:59:59+00:00
Accession:  0001493152-24-015938
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa Therapeutics executes 1-for-10 reverse stock split effective April 25, 2024
--------------------------------------------------------------------------------

- Reverse split ratio 1-for-10; approved by stockholders at special meeting on April 17, 2024.
- Effective at 4:01 p.m. ET on April 25; split-adjusted trading begins April 26 on Nasdaq.
- Par value unchanged; new CUSIP number is 98987D 300.
- Common stock continues trading under symbol ZVSA on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315224015938/0001493152-24-015938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315224015938/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-015938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer